The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) has recognized The Jewish Hospital – Mercy Health as one of 89 ACS NSQIP participating hospitals to achieve meritorious outcomes for surgical patient care in 2019. 

Risk-adjusted data from the July 2020 ACS NSQIP Semiannual Report, which presents data from the 2019 calendar year, were used to determine which hospitals demonstrated meritorious outcomes. ACS recognized The Jewish Hospital on the “High Risk” Meritorious list.

Based on quality scores, high risk patients undergoing surgery at The Jewish Hospital were less likely to experience:

  • Cardiac arrest and heart attack
  • Death
  • More than 48 hours on a ventilator
  • Pneumonia
  • Renal failure
  • Surgical site infections
  • Unplanned intubation
  • Urinary tract infection 

“High risk patients present some of the most challenging cases for any surgical team but our continual focus on providing quality, evidence-based care allows us to provide these patients with the procedures they need in the safest possible way,” said The Jewish Hospital President Pat Davis-Hagens. “I commend our surgical staff for earning this distinction.” 

The 89 commended hospitals achieved the distinction based on their outstanding composite quality score across the eight areas listed above.

As a participant in ACS NSQIP, The Jewish Hospital is required to track the outcomes of inpatient and outpatient surgical procedures and collect data that assesses patient safety and can be used to direct improvement in the quality of surgical care. The ACS NSQIP recognition program commends a select group of hospitals for achieving a meritorious composite score in either an “All Cases” category or a category which includes only “High Risk” cases.

ACS NSQIP is the only nationally validated quality improvement program that measures and enhances the care of surgical patients. This program measures the actual surgical results 30 days postoperatively as well as risk adjusts patient characteristics to compensate for differences among patient populations and acuity levels. 

The goal of ACS NSQIP is to reduce surgical morbidity (infection or illness related to a surgical procedure) and surgical mortality (death related to a surgical procedure) and to provide a firm foundation for surgeons to apply what is known as the “best scientific evidence” to the practice of surgery. Furthermore, when adverse effects from surgical procedures are reduced and/or eliminated, a reduction in health care costs follows. ACS NSQIP is a major program of the American College of Surgeons and is currently used in nearly 850 adult and pediatric hospitals.